View Author
tumor tissue t cells jurkat t cells jurkat response assay patient caix car reporter receptor cancer tumor tissue antigen expression target activation prostate patient-derived tumor tissue cell lines cytokine therapy luciferase / journal medium car-transduced nucleofection caix-negative signi ficantly method -6-luc nucleofected caix-positive patient-derived production control nfat assay experiment nfat activation cancer res skrc 17 cl recovery serum histological table journal speci domain activity material erasmus mc 11–20 il -2 transduced program stimulation membrane schroten condition treatment cell carcinoma lamer reporter gene assay carcinoma nfat -6luc reporter transduction t cell recovery cytokine bead array antigen-speci target cell lines nfat activation assay p b 0.05 fl ow cytometry caix-negative tumor tissue 37 ° c nfat -6-luc reporter level signi serum-containing netherland
2 Most Recent Publications
|
T cell activation upon exposure to patient-derived tumor tissue: A functional assay to select patients for adoptive T cell therapy
(Article)
Schroten-Loef, C. Kraaij, R. Veldhoven, J.L.M. Berrevoets, C.A. Bakker, M.A. den Sadelain, M. Bangma, C.H. Willemsen, R.A. Debets, J.E.M.A. |
2010-07-01
|
|
Generation of a high titer retroviral vector capable of expressing high levels of the human β-globin gene.
(Article)
Sadelain, M. Wang, C.H.J. Antoniou, M. Grosveld, F.G. Mulligan, R.C. |
1995-01-01
|
